CLIA-Validated PBMC Spectral Flow Immune Profiling Assay
Clinical trials-grade immunophenotyping with 25 markers for peripheral blood immune detection
Identify immune biomarkers for dose selection, mechanism of action, and pharmacodynamic studies in your clinical trials.
Analyze up to 298 immune cell subsets and states with our 25-marker spectral cytometry panel. Accurate subset measurements with <5% coefficient of variation for all major immune cell types.
Total Average Coefficient of Variations:
- Intra-Run Precision: 3.66%
- Inter-Run Precision: 3.45%
Validated with cryopreserved human PBMC.
Up to 290+ Immune Subsets and States Analyzed
25-Marker Human PBMC Pan-Immune Profiling Panel
- Markers to identify every major immune cell population and subsets
- 5 functional state markers of maturation, activation, and exhaustion
- Gating performed by our team of expert immunologists
Markers to define cell populations and quantify functional states
Coefficient of Variation (CV) Among Immune Cell Subsets
Precision and Median Cell Count
* = No CV calculated (subset was below 100-cell minimum in >1 replicate)
CLIA Validation Data
25-Marker Spectral Flow Pan-Immune Profiling Test for Human PBMCsFill out the form below to access our CLIA Validation plan, report, and data and SOPs.